Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Feb 1.

Published in final edited form as: Am J Psychiatry. 2017 Oct 3;175(2):150–158. doi: 10.1176/appi.ajp.2017.17040472

Proportion of subjects without suicidal ideation at each time point post-dose using (A) clinician-reported outcome measures (Montgomery-Asberg Depression Rating Scale (MADRS) or Hamilton Depression Rating Scale (HAM-D)) and (B) self-reported outcome measures (Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) or Beck Depressive Inventory (BDI)); *p<0.05, **p<0.01, ***p<0.001. Error bars are 95% confidence intervals.

Proportion of subjects without suicidal ideation at each time point post-dose using (A) clinician-reported outcome measures (Montgomery-Asberg Depression Rating Scale (MADRS) or Hamilton Depression Rating Scale (HAM-D)) and (B) self-reported outcome measures (Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) or Beck Depressive Inventory (BDI)); *p<0.05, **p<0.01, ***p<0.001. Error bars are 95% confidence intervals.